Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 864.30M | 1.89B | 262.23M | 601.95M | 481.12M |
Gross Profit | 12.03M | 19.11M | 10.91M | 11.07M | 17.54M |
EBITDA | -20.26M | 12.34M | 5.60M | 3.63M | 21.25M |
Net Income | -30.78M | 1.84M | -5.45M | -18.30M | -16.90M |
Balance Sheet | |||||
Total Assets | 560.36M | 1.81B | 625.02M | 977.77M | 806.88M |
Cash, Cash Equivalents and Short-Term Investments | 6.50M | 7.53M | 9.02M | 7.52M | 6.09M |
Total Debt | 4.18M | 6.49M | 16.67M | 21.84M | 752.00K |
Total Liabilities | 133.97M | 1.32B | 103.00M | 472.43M | 321.13M |
Stockholders Equity | 435.63M | 493.21M | 531.08M | 514.17M | 494.07M |
Cash Flow | |||||
Free Cash Flow | -708.00K | 8.16M | 8.45M | -148.53M | 342.76M |
Operating Cash Flow | 1.27M | 11.17M | 12.55M | -147.31M | 354.62M |
Investing Cash Flow | -1.96M | -3.01M | -4.09M | 155.47M | -11.44M |
Financing Cash Flow | 0.00 | -9.56M | -6.88M | -6.96M | -399.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $537.05B | 38.13 | 27.96% | 2.31% | 19.20% | 24.01% | |
76 Outperform | HK$4.69T | 22.05 | 21.25% | 0.87% | 8.88% | 54.27% | |
75 Outperform | $47.58B | 11.06 | 9.62% | 3.43% | 11.54% | 16.09% | |
67 Neutral | HK$64.14B | 15.73 | 26.55% | 3.20% | -1.69% | 17.32% | |
59 Neutral | HK$16.42B | 4.45 | -5.52% | 4.84% | -3.57% | -61.41% | |
43 Neutral | HK$210.84M | ― | -11.18% | ― | -78.66% | -1250.00% |